Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

In the latest market close, Eli Lilly (LLY) reached $887.16, with a +0.18% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.9%. Elsewhere, the Dow …

18%
OFF

Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

2 weeks from now

In the latest market close, Eli Lilly (LLY) reached $887.16, with a +0.18% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.9%. Elsewhere, the Dow …

msn.com

18%
OFF

Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

2 weeks from now

Oct 4, 2024 · Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close. Eli Lilly (LLY) Rises But Trails Market: What Investors Should …

zacks.com

4440%
OFF

Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

2 weeks from now

The upcoming earnings release of Eli Lilly will be of great interest to investors. It is anticipated that the company will report an EPS of $4.54, marking a 4440% rise compared to the same quarter ...

yahoo.com

44%
OFF

Eli Lilly (LLY) Stock Slides As Market Rises: Facts To Know Before …

2 weeks from now

Dec 11, 2024 · Eli Lilly (LLY Quick Quote LLY - Free Report) closed at $796.03 in the latest trading session, marking a -0.44% move from the prior day. The stock fell short of the S&P …

zacks.com

44%
OFF

Eli Lilly (LLY) Stock Slides As Market Rises: Facts To Know ... - Nasdaq

2 weeks from now

Dec 11, 2024 · Eli Lilly (LLY) closed at $796.03 in the latest trading session, marking a -0.44% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.82% …

nasdaq.com

50%
OFF

Eli Lilly: Why The Stock Has Been Surging And Why It Could Retain ...

2 weeks from now

Oct 14, 2024 · Lilly Is Fighting Back Against Copycats and Expanding Its Market. Lilly also recently began a program where patients can directly purchase Zepbound for 50% less than …

investing.com

9%
OFF

Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need To …

2 weeks from now

Jan 29, 2024 · Eli Lilly (LLY) ended the recent trading session at $645, demonstrating a +0.9% swing from the preceding day's closing price. The stock exceeded the S&P 500, which …

nasdaq.com

18%
OFF

Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

2 weeks from now

Oct 4, 2024 · In the latest market close, Eli Lilly (LLY) reached $887.16, with a +0.18% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.9%. …

tradingview.com

18%
OFF

Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know

2 weeks from now

Oct 5, 2024 · In the latest market close, Eli Lilly (LLY) reached $887.16, with a +0.18% movement compared to the previous day. This move lagged the S&P 500's daily gain of 0.9%. …

reportify.cc

07%
OFF

Why The Market Dipped But Eli Lilly (LLY) Gained Today

2 weeks from now

Jan 7, 2025 · In the latest trading session, Eli Lilly (LLY Quick Quote LLY - Free Report) closed at $773.29, marking a +1.07% move from the previous day.The stock outpaced the S&P 500's …

zacks.com

$717
OFF

Eli Lilly’s SWOT Analysis: Stock Soars On Diabetes Drug Success, Eyes ...

2 weeks from now

11 hours ago · Eli Lilly and Company (NYSE: LLY), a leading pharmaceutical giant with a market capitalization of $717.9 billion, has been making waves in the biopharmaceutical industry with …

investing.com

44%
OFF

Eli Lilly (NYSE:LLY) Shareholders Have Earned A 44% CAGR Over The …

2 weeks from now

1 day ago · Eli Lilly provided a TSR of 25% over the year (including dividends). That's fairly close to the broader market return. It has to be noted that the recent return falls short of the 44% …

yahoo.com

05%
OFF

David Kalinsack - Managing Director - Financial Service Industry

2 weeks from now

Eli Lilly (LLY) Pharmaceuticals closed up 3.05%, hitting a new closing high! Monkeypox concept stock GeoVax Labs fell 20.56%, Chimerix rose slightly by 0.95%, and once fell by more than …

linkedin.com

08%
OFF

Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know

2 weeks from now

Dec 24, 2024 · Eli Lilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P 500's daily gain of …

nasdaq.com

3%
OFF

Microsoft (MSFT) Stock Falls Amid Market Uptick: What Investors …

2 weeks from now

13 hours ago · Eli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors Eli Lilly (LLY) closed the most recent trading day at $797.48, moving -0.3% from the …

yahoo.com

FAQs about Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know Coupon?

Is Eli Lilly (LLY) a good stock to buy?

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this drugmaker have returned -5.8%, compared to the Zacks S&P 500 composite's -2.8% change. ...

How will Eli Lilly's upcoming earnings release affect investors?

Will Lilly's earnings rise strongly in the future?

Based on Lilly’s next twelve months forward P/E ratio, investors are paying about the same now for each dollar of future earnings as they were in May of 2023. The gap between the backward-looking P/E and the forward-looking P/E suggests a belief that the company's earnings will rise strongly in the future. ...

What are the Zacks consensus estimates for Eli Lilly?

Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $16.49 per share and revenue of $46.33 billion, indicating changes of +160.92% and +35.77%, respectively, compared to the previous year. Investors should also pay attention to any latest changes in analyst estimates for Eli Lilly. ...

What should investors look for in Eli Lilly analyst estimates?

Investors should also pay attention to any latest changes in analyst estimates for Eli Lilly. These revisions help to show the ever-changing nature of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability. ...

Can Eli Lilly keep winning?

Its weight loss and diabetes treatments are growing sales rapidly, but it's not resting on its laurels. Lilly's ability to stay ahead of the game can allow it to keep winning going forward. In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company in the world. ...